Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Left ventricular noncompaction-a rare cause of triad: heart failure, ventricular arrhythmias, and systemic embolic events: a case report. | J Med Case Rep | 2021 | 34099054 | PubTator, text mining | PubMed |
| Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy. | J Biol Chem | 2021 | 34097875 | PubTator, text mining | PubMed |
| Magnesium Deficiency Causes a Reversible, Metabolic, Diastolic Cardiomyopathy. | J Am Heart Assoc | 2021 | 34096318 | PubTator, text mining | PubMed |
Phenotypic Variability of a Pathogenic PKP2 Mutation in an Italian Family Affected by Arrhythmogenic Cardiomyopathy and Juvenile Sudden Death: Considerations From Molecular Autopsy to Sport Restriction. | Front Cardiovasc Med | 2021 | 34095246 | PubTator, text mining | PubMed |
| Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution. | Aging Cell | 2021 | 34092006 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell line (EHTJUi003-A) generated from a neonate with c.1377delC mutation in the gene MYBPC3 causing hypertrophic cardiomyopathy. | Stem Cell Res | 2021 | 34087980 | PubTator, text mining | PubMed |
| Identification of three novel pathogenic mutations in sarcomere genes associated with familial hypertrophic cardiomyopathy based on multi-omics study. | Clin Chim Acta | 2021 | 34087240 | PubTator, text mining | PubMed |
| Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells. | Front Cell Dev Biol | 2021 | 34079803 | PubTator, text mining | PubMed |
| A Novel Mutation in the Myosin Binding Protein C Gene in a Prader-Willi Syndrome Pedigree. | Reprod Sci | 2021 | 34076875 | PubTator, text mining | PubMed |
| Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy. | Int J Mol Sci | 2021 | 34073616 | PubTator, text mining | PubMed |
| The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling. | Cells | 2021 | 34073556 | PubTator, text mining | PubMed |
| Exploration of Potential Genetic Biomarkers for Heart Failure: A Systematic Review. | Int J Environ Res Public Health | 2021 | 34072866 | PubTator, text mining | PubMed |
| Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress. | Int J Mol Sci | 2021 | 34068052 | PubTator, text mining | PubMed |
| Sudden Death without a Clear Cause after Comprehensive Investigation: An Example of Forensic Approach to Atypical/Uncertain Findings. | Diagnostics (Basel) | 2021 | 34067575 | PubTator, text mining | PubMed |
| Update on Biomarkers Associated to Cardioembolic Stroke: A Narrative Review. | Life (Basel) | 2021 | 34067554 | PubTator, text mining | PubMed |
| Variants in MHY7 Gene Cause Arrhythmogenic Cardiomyopathy. | Genes (Basel) | 2021 | 34067482 | PubTator, text mining | PubMed |
| Creating a 'Molecular Band-Aid'; Blocking an Exposed Protease Target Site in Desmoplakin. | J Pers Med | 2021 | 34065787 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies. | J Clin Med | 2021 | 34062949 | PubTator, text mining | PubMed |
| Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy. | ACS Nano | 2021 | 34060810 | PubTator, text mining | PubMed |
| Cardiovascular magnetic resonance detects microvascular dysfunction in a mouse model of hypertrophic cardiomyopathy. | J Cardiovasc Magn Reson | 2021 | 34053450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=66